COVID-19

 

Sub Saharan Africa: Overview

Available on demand For-profit health care is a vital part of provision in all African countries. What has been the impact of Covid?  How far can operators work with new universal healthcare models being rolled out by governments? And how far has the collapse of medical tourism led to more investment in national markets?  This […]

Psychiatry and Mental Health: Sector Analysis

Covid has led to a mental health epidemic that has forced this Cinderella sector to the fore. What role can the private sector play in both inpatient provision and in outpatient and digital settings? Confirmed speakers to include: Emmanuel Masson, Clinea (Orpea) Pierre Forest, INICEA Marja-Leena Tuomola, Terveystalo Chaired by: Dr Adrienne Rivlin, L.E.K. Consutling 

The New Covid-19 Policymaking Landscape

Healthcare has become far more important politically. So governments have become far more proactive and big data sets enable them, often for the first time, to systematically target vulnerable groups with high rates of co-morbidity with new programmes. What are the implications of these revolutionary changes? Confirmed speakers include: Markus Siebert, Abbott Martin Brunninger, Department […]

Funding and Recovery

The pandemic has seen governments redefine their relationship with the for-profit sector. Sometimes it is viewed as a valuable partner, sometimes as a parasite to be controlled and partly nationalised. This session explores what has changed and how the private sector has reacted to these pressures. What are the implications of this new relationship? Confirmed […]

Fertility: Sector Analysis

How has demand been affected by the pandemic? How are technical innovations in treatment and digital health reshaping the sector? What will be the impact of femtech?  And is it now clear that consolidated international groups are viable business models? Confirmed speakers include: Katya Zubareva, L.E.K. Consulting Carlos Blanes Girones, IVI RMA Global David Burford, […]

Diagnostics: Sector Analysis

Covid-19 massively boosted lab revenues. But will labs retain the special relationship they have built with governments?  US groups, for instance, are monetising their data by working with payors on disease prevention. How are labs using digital to help doctors interpret results and to reach the consumer? Confirmed speakers include: Michiel Boehmer, Unilabs Evangelos Kotsopoulos, […]

Dentistry: Sector Analysis

The mass consolidation of the past decade has seen the creation of Pan-European dental chains. But how far has that been disrupted by Covid? What have dental groups had to change about their models to deal with pent-up demand? What digital interventions should dental groups be investing in? Confirmed speakers include: Ben Faircloth, L.E.K. Consulting […]

Investing in Emerging Markets

Covid has had a huge impact, styming medical tourism and hitting profits hard. We hear how it has made investors rethink their approach and business models. What are the new opportunities that are now emerging? Confirmed speakers include: Charles Dalton, IFC Leandro Cuccioli, CDC Massimiliano Colella, Evercare Group Chaired by: Lee Murray, HBI

Investing in Health Care Property

Property investors have fled to health care over the pandemic and are now exploring opportunities far beyond “safe” North American and West European markets. How large are these opportunities and how far are West European countries developing into mature, secondary markets? Where, and how, is the immense public sector opening up to deals with investors? […]

The power of big platforms

What are the advantages of building large international platforms in health care services? What are the synergies between different lines of business? Because of their size can big platforms achieve extra efficiencies in the rollout of digital health and AI? Confirmed speakers include: Sophie Boissard, Korian  Inaki Ereno, Bupa   francesco De Meo, Fresenius Helios […]

Find Us